NRX Pharmaceuticals (NRXP) Other Operating Expenses (2017 - 2026)
NRX Pharmaceuticals (NRXP) posted quarterly Other Operating Expenses of $694000.0 for Q1 2026, up 54.22% quarter-over-quarter from $450000.0 in Q4 2025.
NRX Pharmaceuticals (NRXP) Other Operating Expenses (2017 - 2026) Analysis & Trends
NRX Pharmaceuticals (NRXP) has reported Other Operating Expenses for 8 consecutive years, with $694000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Operating Expenses changed N/A year-over-year to $694000.0; the TTM figure through Mar 2026 stood at $1.3 million (up 42133.33% YoY), while the FY2025 annual figure was $575000.0, up 11400.0% from the prior year.
- Other Operating Expenses advanced to $694000.0 in Q1 2026 per NRXP's latest filing, from $450000.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $694000.0 in Q1 2026 and bottomed at $1000.0 in Q4 2024.
- Historically, Other Operating Expenses has averaged $254000.0 across 3 years, with a median of $123000.0 in 2025.
- On a YoY basis, Other Operating Expenses climbed as much as 44900.0% in 2025 and fell as far as 6050.0% in 2025.
- NRX Pharmaceuticals' Other Operating Expenses stood at $1000.0 in 2024, then jumped by 44900.0% to $450000.0 in 2025, then surged by 54.22% to $694000.0 in 2026.
- Business Quant data shows NRXP's Other Operating Expenses at $694000.0 in Q1 2026, $450000.0 in Q4 2025, and $123000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | NRX Pharmaceuticals | 132.53 Mn | 105.83 Mn | 426,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 694,000.00 |
| Dec 31, 2025 | 450,000.00 |
| Sep 30, 2025 | 123,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Jun 30, 2021 | 10.16 Mn |
| Mar 31, 2021 | 20.60 Mn |
| Dec 31, 2020 | 34.28 Mn |
| Sep 30, 2020 | -2.94 Mn |
| Jun 30, 2020 | -2.02 Mn |
| Mar 31, 2020 | 119,300.00 |
| Dec 31, 2019 | 190,959.00 |
| Sep 30, 2019 | 183,305.00 |
| Jun 30, 2019 | 175,742.00 |
| Mar 31, 2019 | 163,181.00 |
| Sep 30, 2018 | 684,427.00 |
| Jun 30, 2018 | 464,184.00 |
| Mar 31, 2018 | 192,374.00 |
| Dec 31, 2017 | 134,476.00 |